Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation

Published:2024-02-10 Issue:5 Volume:59 Page:688-691
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Yamamoto Ryusuke,Hiramoto Nobuhiro^ORCID,Fujimoto Ayumi^ORCID,Yamazaki Hirohito^ORCID,Mori Takehiko^ORCID,Uchida Naoyuki^ORCID,Doki Noriko^ORCID,Kato Jun^ORCID,Nishikubo Masashi^ORCID,Kako Shinichi^ORCID,Nishida Tetsuya,Ota Shuichi^ORCID,Onizuka Makoto^ORCID,Eto Tetsuya,Onodera Koichi,Ikegame Kazuhiro^ORCID,Matsuoka Ken-ichi^ORCID,Kanda Yoshinobu^ORCID,Fukuda Takahiro,Atsuta Yoshiko^ORCID,Onishi Yasushi^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41409-024-02234-1.pdf

Reference10 articles.

1. Dierickx D, Habermann TM. Post-Transplantation Lymphoproliferative Disorders in Adults. N Engl J Med. 2018;378:549–62.

2. Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Uchida N, Maeda T, et al. Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019;25:1441–9.

3. Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208–16.

4. Landgren O, Gilbert ES, Rizzo JD, Socie G, Banks PM, Sobocinski KA, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009;113:4992–5001.

5. Uhlin M, Wikell H, Sundin M, Blennow O, Maeurer M, Ringden O, et al. Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation. Haematologica. 2014;99:346–52.